Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             152 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bioequivalence comparison of two formulations of rifampicin (300- vs 150-mg capsules): An open-label, randomized, two-treatment, two-way crossover study in healthy volunteers Chik, Zamri
 2010
 32 Supplement 2 p. 1822-1831
10 p.
 artikel
2 A comparison of peginterferon α-2a and α-2b for treatment-naive patients with chronic hepatitis C virus: A meta-analysis of randomized trials Zhao, Sihai
 2010
 32 Supplement 2 p. 1565-1577
13 p.
 artikel
3 Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: Subpopulation analysis of a prospective, open-label extension study of up to 48 weeks Piña-Garza, Jesus Eric
 2010
 32 Supplement 2 p. 1935-1950
16 p.
 artikel
4 Advisory Board 2010
 32 Supplement 2 p. IBC-
1 p.
 artikel
5 Allergic shock and death associated with protamine administration in a diabetic patient Chu, Yan-Qi
 2010
 32 Supplement 2 p. 1729-1732
4 p.
 artikel
6 A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type Nikfar, Shekoufeh
 2010
 32 Supplement 2 p. 1871-1888
18 p.
 artikel
7 Anaphylactoid reaction considered ciprofloxacin related: A case report and literature review Kelesidis, Theodoros
 2010
 32 Supplement 2 p. 515-526
12 p.
 artikel
8 An open-label, randomized, single-center, two-period, phase I, crossover study of the effect of zibotentan (ZD4054) on the pharmacokinetics of midazolam in healthy male volunteers Tomkinson, Helen K.
 2010
 32 Supplement 2 p. 1372-1386
15 p.
 artikel
9 Antipsychotic polypharmacy in the treatment of children and adolescents in the fee-for-service component of a large state medicaid program Constantine, Robert J.
 2010
 32 Supplement 2 p. 949-959
11 p.
 artikel
10 A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses Beran, Jiri
 2010
 32 Supplement 2 p. 2186-2197
12 p.
 artikel
11 A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Repeat-Dose Study of Two Intravenous Acetaminophen Dosing Regimens for the Treatment of Pain After Abdominal Laparoscopic Surgery Wininger, Steven J.
 2010
 32 Supplement 2 p. 2348-2369
22 p.
 artikel
12 A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the united states from 2003 to 2005 Hansen, Richard A.
 2010
 32 Supplement 2 p. 1308-1319
12 p.
 artikel
13 A retrospective, observational cohort analysis of a nationwide database to compare heart failure prescriptions and related health care utilization before and after publication of updated treatment guidelines in the United States Shafazand, Shirin
 2010
 32 Supplement 2 p. 1642-1650
9 p.
 artikel
14 A retrospective, open-label analysis of the population pharmacokinetics of a single 10-mg dose of loratadine in healthy white Jordanian male volunteers Salem, Isam I.
 2010
 32 Supplement 2 p. 391-395
5 p.
 artikel
15 A review of the treatment of chronic hepatitis C virus infection in cirrhosis Vezali, Elena
 2010
 32 Supplement 2 p. 2117-2138
22 p.
 artikel
16 A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: A multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study Mehlisch, Donald R.
 2010
 32 Supplement 2 p. 1033-1049
17 p.
 artikel
17 Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers Stockis, Armel
 2010
 32 Supplement 2 p. 1813-1821
9 p.
 artikel
18 A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients Zheng, Ming-Hua
 2010
 32 Supplement 2 p. 649-658
10 p.
 artikel
19 Besifloxacin: A topical fluoroquinolone for the treatment of bacterial conjunctivitis Chang, Mei H.
 2010
 32 Supplement 2 p. 454-471
18 p.
 artikel
20 Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, two-way crossover study Zhang, Qian
 2010
 32 Supplement 2 p. 171-178
8 p.
 artikel
21 Bioequivalence and pharmacokinetic evaluation of two formulations of glimepiride 2 mg: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy chinese male volunteers Liu, Yun
 2010
 32 Supplement 2 p. 986-995
10 p.
 artikel
22 Bioequivalence evaluation of single doses of two tramadol formulations: A randomized, open-label, two-period Silva, Marina de Freitas
 2010
 32 Supplement 2 p. 758-765
8 p.
 artikel
23 Bioequivalence of two tablet formulations of clopidogrel in healthy argentinian volunteers: A single-dose, randomized-sequence, open-label crossover study Di Girolamo, Guillermo
 2010
 32 Supplement 2 p. 161-170
10 p.
 artikel
24 Buprenorphine transdermal system in adults with chronic low back pain: A randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase Gordon, Allan
 2010
 32 Supplement 2 p. 844-860
17 p.
 artikel
25 Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary report Chen, Mei-Ling
 2010
 32 Supplement 2 p. 1704-1712
9 p.
 artikel
26 Changes in the QTc interval after administration of flecainide acetate, with and without coadministered Paroxetine, in Relation to Cytochrome P450 2D6 Genotype: Data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects Lim, Kyoung Soo
 2010
 32 Supplement 2 p. 659-666
8 p.
 artikel
27 Clinical efficacy and tolerability of linezolid in pediatric patients: A systematic review Chiappini, Elena
 2010
 32 Supplement 2 p. 66-88
23 p.
 artikel
28 Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: A single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers Ahmad, Mahmood
 2010
 32 Supplement 2 p. 607-613
7 p.
 artikel
29 Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: An open-label, randomized-sequence, two-period crossover study Shi, Shaojun
 2010
 32 Supplement 2 p. 1977-1986
10 p.
 artikel
30 Comparative resource utilization in medicaid-eligible patients with asthma treated with fixed-dose fluticasone propionate/salmeterol or fluticasone propionate monotherapy Stanford, Richard H.
 2010
 32 Supplement 2 p. 1782-1793
12 p.
 artikel
31 Comparison of Atorvastatin 5 and 20 mg/d for Reducing F-18 Fluorodeoxyglucose Uptake in Atherosclerotic Plaques on Positron Emission Tomography/Computed Tomography: A Randomized, Investigator-Blinded, Open-Label, 6-Month Study in Japanese Adults Scheduled for Percutaneous Coronary Intervention Ishii, Hideki
 2010
 32 Supplement 2 p. 2337-2347
11 p.
 artikel
32 Comparison of effects of two different formulations of clopidogrel bisulfate tablets on platelet aggregation and bleeding time in healthy Korean volunteers: A single-dose, randomized, open-label, 1-week, two-period, phase IV crossover study Shim, Chi Young
 2010
 32 Supplement 2 p. 1664-1673
10 p.
 artikel
33 Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study Crank, Christopher W.
 2010
 32 Supplement 2 p. 1713-1719
7 p.
 artikel
34 Comparison of the analgesic efficacy of concurrent ibuprofen and paracetamol with ibuprofen or paracetamol alone in the management of moderate to severe acute postoperative dental pain in adolescents and adults: A randomized, double-blind, placebo-controlled, parallel-group, single-dose, two-center, modified factorial study Mehlisch, Donald R.
 2010
 32 Supplement 2 p. 882-895
14 p.
 artikel
35 Comparison of the bioavailability and tolerability of fixed-dose combination glimepiride/metformin 2/500-mg tablets versus separate tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Korean volunteers Gu, Namyi
 2010
 32 Supplement 2 p. 1408-1418
11 p.
 artikel
36 Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: A 4-week, prospective, open-label, randomized, parallel-group, noninferiority study Wang, Tsung-Jen
 2010
 32 Supplement 2 p. 44-52
9 p.
 artikel
37 Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system Moreno, Santiago
 2010
 32 Supplement 2 p. 2232-2245
14 p.
 artikel
38 Cost-effectiveness of ranibizumab for the treatment of neovascular age-related macular degeneration in germany: Model analysis from the perspective of germany's statutory health insurance system Neubauer, Aljoscha S.
 2010
 32 Supplement 2 p. 1343-1356
14 p.
 artikel
39 Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system Emerson, Christopher R.
 2010
 32 Supplement 2 p. 1578-1596
19 p.
 artikel
40 Dried blood spots as a sample type in acid α-glucosidase enzyme assays for Pompe disease Lukacs, Zoltan
 2010
 32 Supplement 2 p. S53-S54
2 p.
 artikel
41 Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-Month, single-arm, open-label clinical trial in patient-caregiver dyads Hey-Hadavi, Judith
 2010
 32 Supplement 2 p. 2036-2047
12 p.
 artikel
42 Editorial Board 2010
 32 Supplement 2 p. IFC-
1 p.
 artikel
43 Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: Meta-analysis of prospective studies Zanini, Barbara
 2010
 32 Supplement 2 p. 2139-2159
21 p.
 artikel
44 Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study Parati, Gianfranco
 2010
 32 Supplement 2 p. 1270-1284
15 p.
 artikel
45 Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study Vaz-da-Silva, Manuel
 2010
 32 Supplement 2 p. 179-192
14 p.
 artikel
46 Effect of heart failure exacerbations on anticoagulation: A prospective, observational, pilot cohort study Ripley, Toni L.
 2010
 32 Supplement 2 p. 506-514
9 p.
 artikel
47 Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression Friedrich, Megan
 2010
 32 Supplement 2 p. 1221-1233
13 p.
 artikel
48 Effects of glatiramer acetate on spasticity in previously interferon-β-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: A prospective, nonrandomized, open-label, uncontrolled, observational pilot study Meca-Lallana, José Eustasio
 2010
 32 Supplement 2 p. 1061-1066
6 p.
 artikel
49 Effects of hepatic impairment on the steady-state pharmacokinetics of etravirine 200 mg BID: An open-label, multiple-dose, controlled Phase I study in adults Schöller-Gyüre, Monika
 2010
 32 Supplement 2 p. 328-337
10 p.
 artikel
50 Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: A randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder Miceli, Jeffrey J.
 2010
 32 Supplement 2 p. 472-491
20 p.
 artikel
51 Effects of oral cilostazol 100 mg BID on long-term patency after percutaneous transluminal angioplasty in patients with femoropopliteal disease undergoing hemodialysis: A retrospective chart review in Japanese patients Ishii, Hideki
 2010
 32 Supplement 2 p. 24-33
10 p.
 artikel
52 Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: A systematic literature review van Riet-Nales, Diana A.
 2010
 32 Supplement 2 p. 924-938
15 p.
 artikel
53 Efficacy and safety profile of a topical methyl salicylate and menthol patch in adult patients with mild to moderate muscle strain: A randomized, double-blind, parallel-group, placebo-controlled, multicenter study Higashi, Yoshinobu
 2010
 32 Supplement 2 p. 34-43
10 p.
 artikel
54 Efficacy and tolerability of a generic and a branded formulation of atorvastatin 20 mg/d in hypercholesterolemic Korean adults at high risk for cardiovascular disease: A multicenter, prospective, randomized, double-blind, double-dummy clinical trial Kim, Sang-Hyun
 2010
 32 Supplement 2 p. 1896-1905
10 p.
 artikel
55 Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: A multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study Graff, Gavin R.
 2010
 32 Supplement 2 p. 89-103
15 p.
 artikel
56 Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants Gouyon, Jean-Bernard
 2010
 32 Supplement 2 p. 1740-1748
9 p.
 artikel
57 Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: A 1-week, randomized, open-label study in chinese adults Pan, Xiaolin
 2010
 32 Supplement 2 p. 2003-2011
9 p.
 artikel
58 Efficacy and Tolerability of Pregabalin Using a Flexible, Optimized Dose Schedule in Korean Patients With Peripheral Neuropathic Pain: A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Moon, Dong Eon
 2010
 32 Supplement 2 p. 2370-2385
16 p.
 artikel
59 Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: A retrospective, observational, sequential cohort analysis Kubiak, David W.
 2010
 32 Supplement 2 p. 637-648
12 p.
 artikel
60 Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor Boyce, Eric G.
 2010
 32 Supplement 2 p. 1681-1703
23 p.
 artikel
61 Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease Koyasu, Masayoshi
 2010
 32 Supplement 2 p. 1610-1617
8 p.
 artikel
62 Impact of prior authorization for asthma medications on the use of emergency health services: A retrospective cohort study among newly diagnosed patients with asthma Guénette, Line
 2010
 32 Supplement 2 p. 965-972
8 p.
 artikel
63 Impact of 6 weeks of treatment with low-dose metformin and atorvastatin on glucose-induced changes of endothelial function in adults with newly diagnosed type 2 diabetes mellitus: A single-blind study Tousoulis, Dimitris
 2010
 32 Supplement 2 p. 1720-1728
9 p.
 artikel
64 Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan Hsiang, Kuo-Wei
 2010
 32 Supplement 2 p. 1294-1303
10 p.
 artikel
65 Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: An open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers Kim, Bo-Hyung
 2010
 32 Supplement 2 p. 380-390
11 p.
 artikel
66 Intuitiveness, ease of use, and preference of a prefilled growth hormone injection pen: A noninterventional, randomized, open-label, crossover, comparative usability study of three delivery devices in growth hormone-treated pediatric patients Pfützner, Andreas
 2010
 32 Supplement 2 p. 1918-1934
17 p.
 artikel
67 Irreversible encephalopathy after treatment with high-dose intravenous metronidazole Groothoff, Miriam V.R.
 2010
 32 Supplement 2 p. 60-64
5 p.
 artikel
68 Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects Sarashina, Akiko
 2010
 32 Supplement 2 p. 1188-1204
17 p.
 artikel
69 Long-term visual safety of voriconazole in adult patients with paracoccidioidomycosis Laties, Alan M.
 2010
 32 Supplement 2 p. 2207-2217
11 p.
 artikel
70 Melanoma onset after estrogen, thyroid, and growth hormone replacement therapy Caldarola, Giacomo
 2010
 32 Supplement 2 p. 57-59
3 p.
 artikel
71 Modulation of CD20 antigen expression after rituximab treatment: A retrospective study in patients with chronic lymphocytic leukemia D’Auria, Fiorella
 2010
 32 Supplement 2 p. 1911-1916
6 p.
 artikel
72 Monoclonal antibodies in the treatment of metastatic colorectal cancer: A review Tol, Jolien
 2010
 32 Supplement 2 p. 437-453
17 p.
 artikel
73 Mycophenolate mofetil 500-mg tablet under fasting conditions: Single-dose, randomized-sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjects Almeida, Susana
 2010
 32 Supplement 2 p. 556-574
19 p.
 artikel
74 Nonadherence to oral linezolid after hospitalization: A retrospective claims analysis of the incidence and consequence of claim reversals Ball, Amy T.
 2010
 32 Supplement 2 p. 2246-2255
10 p.
 artikel
75 Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: A prospective, randomized, open-label, placebo-controlled pilot study Arrieta, Antonio C.
 2010
 32 Supplement 2 p. 265-271
7 p.
 artikel
76 Onset of relief of symptoms of gastroesophageal reflux disease: Post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily Haag, Sebastian
 2010
 32 Supplement 2 p. 678-690
13 p.
 artikel
77 Open, uncontrolled, nonrandomized, 9-month, off-label use of bupropion to treat fatigue in a single patient with multiple sclerosis Siniscalchi, Antonio
 2010
 32 Supplement 2 p. 2030-2034
5 p.
 artikel
78 Outpatient treatment of propionic acidemia-associated hyperammonemia with N-carbamoyl-l-glutamate in an infant Soyucen, Erdogan
 2010
 32 Supplement 2 p. 710-713
4 p.
 artikel
79 Parents' decision-making regarding vaccinating their children against influenza: A web-based survey Flood, Emuella M.
 2010
 32 Supplement 2 p. 1448-1467
20 p.
 artikel
80 Partnering with the Pompe disease patient community Schaller, Thomas
 2010
 32 Supplement 2 p. S65-
1 p.
 artikel
81 Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population Bollinger, Mary Elizabeth
 2010
 32 Supplement 2 p. 1093-1102
10 p.
 artikel
82 Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis Moisan, Jocelyne
 2010
 32 Supplement 2 p. S21-S31
11 p.
 artikel
83 Pharmacodynamic (Hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: Two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studies Kim, Bo-Hyung
 2010
 32 Supplement 2 p. 193-205
13 p.
 artikel
84 Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy chinese and white volunteers: An open-label trial Small, David S.
 2010
 32 Supplement 2 p. 365-379
15 p.
 artikel
85 Pharmacokinetic and pharmacodynamic comparison of two recombinant human erythropoietin formulations after single subcutaneous administration: An open-label, sequence-randomized, two-treatment crossover study in healthy Korean male volunteers Kim, Tae-Eun
 2010
 32 Supplement 2 p. 1968-1976
9 p.
 artikel
86 Pharmacokinetic comparison of controlled-release and immediate-release oral formulations of simvastatin in healthy Korean subjects: A randomized, open-label, parallel-group, single- and multiple-dose study Jang, Seong Bok
 2010
 32 Supplement 2 p. 206-216
11 p.
 artikel
87 Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: A randomized, open-label, single-dose, two-way crossover study in adult smokers DeVeaugh-Geiss, Angela M.
 2010
 32 Supplement 2 p. 1140-1148
9 p.
 artikel
88 Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/ probenecid (333 mg): A randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers Wu, Huizhe
 2010
 32 Supplement 2 p. 597-606
10 p.
 artikel
89 Pharmacokinetics, analgesic effect, and tolerability of a single preprocedural dose of intranasal fentanyl in patients undergoing drain removal after breast reduction or augmentation surgery: A prospective, randomized, double-blind, placebo-controlled study Veldhorst-Janssen, Nicole M.L.
 2010
 32 Supplement 2 p. 1427-1436
10 p.
 artikel
90 Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males Liu, Yan-Mei
 2010
 32 Supplement 2 p. 1396-1407
12 p.
 artikel
91 Pharmacokinetics and bioequivalence evaluation of two losartan potassium 50-mg tablets: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers Jia, Jing-Ying
 2010
 32 Supplement 2 p. 1387-1395
9 p.
 artikel
92 Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: A single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers Iqbal, Muzaffar
 2010
 32 Supplement 2 p. 588-596
9 p.
 artikel
93 Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: A randomized, open-label, three-period crossover study in healthy volunteers Berges, Alienor
 2010
 32 Supplement 2 p. 1165-1177
13 p.
 artikel
94 Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: A randomized, open-label, crossover study Darwish, Mona
 2010
 32 Supplement 2 p. 2074-2087
14 p.
 artikel
95 Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: A single-dose, randomized, open-label, crossover study Boellner, Samuel W.
 2010
 32 Supplement 2 p. 252-264
13 p.
 artikel
96 Pharmacokinetics of rosuvastatin in healthy Chinese volunteers living in China: A randomized, open-label, ascending single- and multiple-dose study Li, Xue-Ning
 2010
 32 Supplement 2 p. 575-587
13 p.
 artikel
97 Preconception Steroid Treatment in Infertile Women with Antithyroid Autoimmunity Undergoing Ovarian Stimulation and Intrauterine Insemination: A Double-Blind, Randomized, Prospective Cohort Study Turi, Angelo
 2010
 32 Supplement 2 p. 2415-2421
7 p.
 artikel
98 Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: A Monte Carlo simulation Frymoyer, Adam
 2010
 32 Supplement 2 p. 534-542
9 p.
 artikel
99 Preference for formulations containing calcium and vitamin D3 in childhood: A randomized-sequence, open-label trial Bianchetti, Alessandra A.
 2010
 32 Supplement 2 p. 1083-1087
5 p.
 artikel
100 Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study Pérez, Concepción
 2010
 32 Supplement 2 p. 1357-1370
14 p.
 artikel
101 Pregnancy outcome in a Pompe disease patient treated with enzyme replacement therapy Lindberg, Christopher
 2010
 32 Supplement 2 p. S52-
1 p.
 artikel
102 Prevalence, Cumulative Incidence, Monotherapy and Combination Therapy, and Treatment Duration of Frequently Prescribed Psychoactive Medications in the Netherlands: Retrospective Database Analysis for the Years 2000 to 2005 Ravera, Silvia
 2010
 32 Supplement 2 p. 2457-2466
10 p.
 artikel
103 Propofol/dexmedetomidine and propofol/ketamine combinations for anesthesia in pediatric patients undergoing transcatheter atrial septal defect closure: A prospective randomized study Koruk, Senem
 2010
 32 Supplement 2 p. 701-709
9 p.
 artikel
104 Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: A noninferiority intensification substudy of the DURABLE trial Miser, William F.
 2010
 32 Supplement 2 p. 896-908
13 p.
 artikel
105 Randomized trials of dopamine agonists in restless legs syndrome: A systematic review, quality assessment, and meta-analysis Zintzaras, Elias
 2010
 32 Supplement 2 p. 221-237
17 p.
 artikel
106 Rationale and design of the PREVENT-HIT study: A randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis Frame, James N.
 2010
 32 Supplement 2 p. 626-636
11 p.
 artikel
107 Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in australian patients: A cross-sectional, multicenter study Standfield, Lachlan
 2010
 32 Supplement 2 p. 1329-1342
14 p.
 artikel
108 Relative bioavailability and pharmacokinetic comparison of two 2-mg risperidone tablet formulations: A single dose, randomized-sequence, double-blind, 2-way crossover study in healthy male volunteers in thailand Boonleang, Jutima
 2010
 32 Supplement 2 p. 1842-1853
12 p.
 artikel
109 Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study Ullah, Md. Ashik
 2010
 32 Supplement 2 p. 1419-1426
8 p.
 artikel
110 Relative Bioavailability and Tolerability of Two Formulations of Bicalutamide 50-mg Tablets: A Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Korean Male Subjects Lee, SeungHwan
 2010
 32 Supplement 2 p. 2496-2501
6 p.
 artikel
111 Relative bioavailability of generic and branded acetylcysteine effervescent tablets: A single-dose, open-label, randomized-sequence, two-period crossover study in fasting healthy chinese male volunteers Liu, Yan-Mei
 2010
 32 Supplement 2 p. 2097-2105
9 p.
 artikel
112 Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: A randomized, open-label, crossover study in healthy adults Musson, Donald G.
 2010
 32 Supplement 2 p. 338-346
9 p.
 artikel
113 Relative bioavailability of two formulations of nevirapine 200-mg tablets in healthy Chinese male volunteers: A single-dose, randomized-sequence, open-label, two-way crossover study Zhu, Yubing
 2010
 32 Supplement 2 p. 2258-2264
7 p.
 artikel
114 Relative bioavailability of two formulations of venlafaxine extended-release 75-mg capsules in healthy brazilian male volunteers: A single-dose, randomized-sequence, open-label, two-period crossover study in the fasting and fed states Homero de Souza Filho, José
 2010
 32 Supplement 2 p. 2088-2096
9 p.
 artikel
115 Relative bioavailability of two oral formulations of piroxicam 20 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers Palma-Aguirre, Jose Antonio
 2010
 32 Supplement 2 p. 357-364
8 p.
 artikel
116 Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers Belotto, Karisa Cristina Rodrigues
 2010
 32 Supplement 2 p. 2106-2115
10 p.
 artikel
117 Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence Blais, Lucie
 2010
 32 Supplement 2 p. 1320-1328
9 p.
 artikel
118 Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: A single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteers Johnson, Franklin K.
 2010
 32 Supplement 2 p. 1149-1164
16 p.
 artikel
119 Respiratory syncytial virus testing during bronchiolitis episodes of care in an integrated health care delivery system: A retrospective cohort study Flaherman, Valerie
 2010
 32 Supplement 2 p. 2220-2229
10 p.
 artikel
120 Results of a model analysis of the cost-effectiveness of liraglutide versus exenatide added to metformin, glimepiride, or both for the treatment of type 2 diabetes in the United States Lee, Won Chan
 2010
 32 Supplement 2 p. 1756-1767
12 p.
 artikel
121 Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy Corrao, Giovanni
 2010
 32 Supplement 2 p. 300-310
11 p.
 artikel
122 Retrospective case series of three patients with plasma cell leukemia treated with bortezomib-based regimens Meie, Giuseppe
 2010
 32 Supplement 2 p. 915-919
5 p.
 artikel
123 Retrospective cohort study of hospitalized adults treated with vancomycin or clindamycin for methicillin-resistant Staphylococcus aureus skin infections Frei, Christopher R.
 2010
 32 Supplement 2 p. 2024-2029
6 p.
 artikel
124 Reversal of refractory sulfasalazine-related renal failure after treatment with corticosteroids Alivanis, Polichronis
 2010
 32 Supplement 2 p. 1906-1910
5 p.
 artikel
125 Review of regulatory recommendations for orphan drug submissions in the netherlands and scotland: focus on the underlying pharmacoeconomic evaluations Vegter, Stefan
 2010
 32 Supplement 2 p. 1651-1661
11 p.
 artikel
126 Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis John Camm, A.
 2010
 32 Supplement 2 p. 426-436
11 p.
 artikel
127 Review of the efficacy and tolerability of the diclofenac epolamine topical patch 1.3% in patients with acute pain due to soft tissue injuries Kuehl, Kerry S.
 2010
 32 Supplement 2 p. 1001-1014
14 p.
 artikel
128 Safety and efficacy of esreboxetine in patients with fibromyalgia: An 8-week, multicenter, randomized, double-blind, placebo-controlled study Arnold, Lesley M.
 2010
 32 Supplement 2 p. 1618-1632
15 p.
 artikel
129 Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers Vaughan, David
 2010
 32 Supplement 2 p. 146-160
15 p.
 artikel
130 Safety and tolerability of lersivirine, a nonnucleoside reverse transcriptase inhibitor, during a 28-day, randomized, placebo-controlled, Phase I clinical study in healthy male volunteers Davis, John
 2010
 32 Supplement 2 p. 1889-1895
7 p.
 artikel
131 Serious Early Childhood Wheezing After Respiratory Syncytial Virus Lower Respiratory Tract Illness in Preterm Infants Romero, José R.
 2010
 32 Supplement 2 p. 2422-2432
11 p.
 artikel
132 Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists Miller, Bradley S.
 2010
 32 Supplement 2 p. 1749-1751
3 p.
 artikel
133 Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events Scheiman, James M.
 2010
 32 Supplement 2 p. 667-677
11 p.
 artikel
134 Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing Stubenrauch, Kay
 2010
 32 Supplement 2 p. 1597-1609
13 p.
 artikel
135 Successful pregnancy and lactation outcome in a patient with Gaucher disease receiving enzyme replacement therapy, and the subsequent distribution and excretion of imiglucerase in human breast milk Sekijima, Yoshiki
 2010
 32 Supplement 2 p. 2048-2052
5 p.
 artikel
136 Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy Suzuki, Takaaki
 2010
 32 Supplement 2 p. 527-531
5 p.
 artikel
137 Supplemental calcium in the chemoprevention of colorectal cancer: A systematic review and meta-analysis Carroll, Christopher
 2010
 32 Supplement 2 p. 789-803
15 p.
 artikel
138 Systematic Review and Meta-Analysis of the Efficacy and Tolerability of Nicotine Preparations in Active Ulcerative Colitis Nikfar, Shekoufeh
 2010
 32 Supplement 2 p. 2304-2315
12 p.
 artikel
139 Telavancin: A lipoglycopeptide antimicrobial for the treatment of complicated skin and skin structure infections caused by gram-positive bacteria in adults Chang, Mei H.
 2010
 32 Supplement 2 p. 2160-2185
26 p.
 artikel
140 The economic implications of treating atherothrombotic disease in australia, from the government perspective Ademi, Zanfina
 2010
 32 Supplement 2 p. 119-132
14 p.
 artikel
141 The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: A cross-sectional study in Iran Namazi, Soha
 2010
 32 Supplement 2 p. 1050-1060
11 p.
 artikel
142 The potential importance of renal biopsies in early management decisions in young fabry patients Svarstad, Einar
 2010
 32 Supplement 2 p. S97-S98
2 p.
 artikel
143 The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the jiangsu province of China Bi, Yan
 2010
 32 Supplement 2 p. 973-983
11 p.
 artikel
144 Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: A 24-week, randomized, open-label, follow-up study in China Zou, Li-Ping
 2010
 32 Supplement 2 p. 692-700
9 p.
 artikel
145 Tolerability and Outcomes of Kinetically Guided Therapy With Gentamicin in Critically Ill Neonates During the First Week of Life: An Open-Label, Prospective Study Martínková, Jirina
 2010
 32 Supplement 2 p. 2400-2414
15 p.
 artikel
146 Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: A single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers Jung, Jinah
 2010
 32 Supplement 2 p. 1178-1187
10 p.
 artikel
147 Tolerability and pharmacokinetics of TB-402 in healthy male volunteers Verhamme, Peter
 2010
 32 Supplement 2 p. 1205-1220
16 p.
 artikel
148 Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinib Stein, Brady
 2010
 32 Supplement 2 p. 804-820
17 p.
 artikel
149 Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: A descriptive report Donato, Bonnie M.K.
 2010
 32 Supplement 2 p. 546-554
9 p.
 artikel
150 Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study Oparil, Suzanne
 2010
 32 Supplement 2 p. 1252-1269
18 p.
 artikel
151 Warfarin and bosentan interaction in a patient with pulmonary hypertension secondary to bilateral pulmonary emboli Spangler, Mikayla L.
 2010
 32 Supplement 2 p. 53-56
4 p.
 artikel
152 Willingness to pay for three hypothetical malaria vaccines in Nigeria Udezi, Waka Anthony
 2010
 32 Supplement 2 p. 1533-1544
12 p.
 artikel
                             152 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland